| Permutation tests for joinpoint regression with applications to cancer rates HJ Kim, MP Fay, EJ Feuer, DN Midthune Statistics in medicine 19 (3), 335-351, 2000 | 5558 | 2000 |
| Wilcoxon-Mann-Whitney or t-test? On assumptions for hypothesis tests and multiple interpretations of decision rules MP Fay, MA Proschan Statistics surveys 4, 1, 2010 | 1291 | 2010 |
| In vivo imaging reveals an essential role for neutrophils in leishmaniasis transmitted by sand flies NC Peters, JG Egen, N Secundino, A Debrabant, N Kimblin, S Kamhawi, ... Science 321 (5891), 970-974, 2008 | 1031 | 2008 |
| Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial PB Gilbert, DC Montefiori, AB McDermott, Y Fong, D Benkeser, W Deng, ... Science 375 (6576), 43-50, 2022 | 967 | 2022 |
| Confidence intervals for directly standardized rates: a method based on the gamma distribution MP Fay, EJ Feuer Statistics in medicine 16 (7), 791-801, 1997 | 651 | 1997 |
| Phase 1 trial of malaria transmission blocking vaccine candidates Pfs25 and Pvs25 formulated with montanide ISA 51 Y Wu, RD Ellis, D Shaffer, E Fontes, EM Malkin, S Mahanty, MP Fay, ... PloS one 3 (7), e2636, 2008 | 511 | 2008 |
| Dihydroartemisinin–piperaquine resistance in Plasmodium falciparum malaria in Cambodia: a multisite prospective cohort study C Amaratunga, P Lim, S Suon, S Sreng, S Mao, C Sopha, B Sam, D Dek, ... The Lancet infectious diseases 16 (3), 357-365, 2016 | 494 | 2016 |
| Exact and asymptotic weighted logrank tests for interval censored data: the interval R package MP Fay, PA Shaw Journal of statistical software 36 (2), 2010 | 449 | 2010 |
| Artemisinin-resistant Plasmodium falciparum in Pursat province, western Cambodia: a parasite clearance rate study C Amaratunga, S Sreng, S Suon, ES Phelps, K Stepniewska, P Lim, ... The Lancet infectious diseases 12 (11), 851-858, 2012 | 405 | 2012 |
| Safety and efficacy of PfSPZ Vaccine against Plasmodium falciparum via direct venous inoculation in healthy malaria-exposed adults in Mali: a randomised, double-blind phase 1 trial MS Sissoko, SA Healy, A Katile, F Omaswa, I Zaidi, EE Gabriel, B Kamate, ... The Lancet infectious diseases 17 (5), 498-509, 2017 | 349 | 2017 |
| Geographic patterns of Plasmodium falciparum drug resistance distinguished by differential responses to amodiaquine and chloroquine JM Sá, O Twu, K Hayton, S Reyes, MP Fay, P Ringwald, TE Wellems Proceedings of the National Academy of Sciences 106 (45), 18883-18889, 2009 | 332 | 2009 |
| Comparability of segmented line regression models HJ Kim, MP Fay, B Yu, MJ Barrett, EJ Feuer Biometrics 60 (4), 1005-1014, 2004 | 326 | 2004 |
| Small‐sample adjustments for Wald‐type tests using sandwich estimators MP Fay, BI Graubard Biometrics 57 (4), 1198-1206, 2001 | 312 | 2001 |
| Effect of different types and amounts of fat on the development of mammary tumors in rodents: a review MP Fay, LS Freedman, CK Clifford, DN Midthune Cancer research 57 (18), 3979-3988, 1997 | 295 | 1997 |
| Impact of reporting delay and reporting error on cancer incidence rates and trends LX Clegg, EJ Feuer, DN Midthune, MP Fay, BF Hankey Journal of the National Cancer Institute 94 (20), 1537-1545, 2002 | 294 | 2002 |
| A randomized controlled phase 2 trial of the blood stage AMA1-C1/Alhydrogel malaria vaccine in children in Mali I Sagara, A Dicko, RD Ellis, MP Fay, SI Diawara, MH Assadou, ... Vaccine 27 (23), 3090-3098, 2009 | 239 | 2009 |
| Two-sided exact tests and matching confidence intervals for discrete data. MP Fay R J. 2 (1), 53, 2010 | 237 | 2010 |
| Quantification of the infectious dose of Leishmania major transmitted to the skin by single sand flies N Kimblin, N Peters, A Debrabant, N Secundino, J Egen, P Lawyer, ... Proceedings of the National Academy of Sciences 105 (29), 10125-10130, 2008 | 234 | 2008 |
| Estimating average annual percent change for disease rates without assuming constant change MP Fay, RC Tiwari, EJ Feuer, Z Zou Biometrics 62 (3), 847-854, 2006 | 231 | 2006 |
| Epitools: epidemiology tools TJ Aragon, MP Fay, D Wollschlaeger, A Omidpanah R package version 0.5-10.1 462, 2020 | 209 | 2020 |
Amy Klion在 nih.gov 的电子邮件经过验证
